MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products
MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products Drug alert number: EL(25)A/21 Date issued: 13 May 2025 Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information [...]
The post MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products appeared first on Community Pharmacy England.
Recent Comments